Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China

Int J Infect Dis. 2020 Jul:96:683-687. doi: 10.1016/j.ijid.2020.05.068. Epub 2020 May 26.

Abstract

Objective: To delineate the clinical characteristics of critically ill COVID-19 patients co-infected with influenza.

Methods: This study included adult patients with laboratory-confirmed COVID-19 form Tongji Hospital (Wuhan, China), with or without influenza, and compared their clinical characteristics.

Results: Among 93 patients, 44 died and 49 were discharged. Forty-four (47.3%) were infected with influenza virus A and two (2.2%) with influenza virus B. Twenty-two (50.0%) of the non-survivors and 24 (49.0%) of the survivors were infected with the influenza virus. Critically ill COVID-19 patients with influenza were more prone to cardiac injury than those without influenza. For the laboratory indicators at admission the following were higher in non-survivors with influenza than in those without influenza: white blood cell counts, neutrophil counts, levels of tumor necrosis factor-α, D-dimer value, and proportion of elevated creatinine.

Conclusion: The results showed that a high proportion of COVID-19 patients were co-infected with influenza in Tongji Hospital, with no significant difference in the proportion of co-infection between survivors and non-survivors. The critically ill COVID-19 patients with influenza exhibited more severe inflammation and organ injury, indicating that co-infection with the influenza virus may induce an earlier and more frequently occurring cytokine storm.

Keywords: COVID-19; Co-infection; Cytokine storm; Influenza; Organ injury.

MeSH terms

  • Aged
  • Betacoronavirus
  • COVID-19
  • China / epidemiology
  • Coinfection / virology*
  • Coronavirus Infections / complications
  • Coronavirus Infections / diagnosis*
  • Critical Illness
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Hospitalization
  • Humans
  • Influenza, Human / complications
  • Influenza, Human / diagnosis*
  • Leukocyte Count
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / diagnosis*
  • SARS-CoV-2
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Fibrin Fibrinogen Degradation Products
  • Tumor Necrosis Factor-alpha
  • fibrin fragment D